Prevalence and clinical significance of occult hepatitis B virus infection among renal transplant recipients in Korea

References

• Raimondo G, Navarra G, Mondello S, Costantino L, Colloredo G, Cucinotta E, . Occult hepatitis B virus in liver tissue of individuals without hepatic disease. J Hepatol 2008;48:743–6.
   PubMed Web of Science ®Google Scholar
• Romero M, Madejón A, Fernández-Rodríguez C, García-Samaniego J. Clinical significance of occult hepatitis B virus infection. World J Gastroenterol 2011;17:1549–52.
   PubMed Web of Science ®Google Scholar
• Lledó JL, Fernández C, Gutiérrez ML, Ocaña S. Management of occult hepatitis B virus infection: an update for the clinician. World J Gastroenterol 2011;17:1563–8.
   Google Scholar
• Schmeltzer P, Sherman K. Occult hepatitis B: clinical implications and treatment decisions. Dig Dis Sci 2010;55:3328–35.
   PubMed Web of Science ®Google Scholar
• Lo YM, Lo ES, Mehal WZ, Sampietro M, Fiorelli G, Ronchi G, . Geographical variation in prevalence of hepatitis B virus DNA in HBsAg negative patients. J Clin Pathol 1993;46:304–8.
   Google Scholar
• Song EY, Yun YM, Park MH, Seo DH. Prevalence of occult hepatitis B virus infection in a general adult population in Korea. Intervirology 2009;52:57–62.
   PubMed Web of Science ®Google Scholar
• Jeong S, Yim HW, Bae SH, Lee W. Changes of hepatitis B surface antigen seroprevalence in Korea, 1998–2005. Korean J Epidemiol 2008;30:119–27.
   Google Scholar
• Seo DH, Whang DH, Song EY, Kim HS, Park Q. Prevalence of antibodies to hepatitis B core antigen and occult hepatitis B virus infections in Korean blood donors. Transfusion 2011;51:1840–6.
   PubMed Web of Science ®Google Scholar
• Mina P, Georgiadou SP, Rizos C, Dalekos GN, Rigopoulou EI. Prevalence of occult hepatitis B virus infection in haemodialysis patients from central Greece. World J Gastroenterol 2010;14:225–31.
   Google Scholar
• Goncales FL Jr, Pereira JS, Da Silva C, Thomaz GR, Pavan MH, Fais VC, . Hepatitis B virus DNA in sera of blood donors and of patients infected with hepatitis C virus and human immunodeficiency virus. Clin Diagn Lab Immunol 2003;10:718–20.
   Google Scholar
• Giudice CL, Martinengo M, Pietrasanta P, Bocciardo L, Malavasi C, Rastelli S, . Occult hepatitis B virus infection: a case of reactivation in a patient receiving immunosuppressive treatment for allogeneic bone marrow transplantation. Blood Transfus 2008;6:46–50.
   Google Scholar
• Peres AA, Dias EA, Chesky M, Alvares-da-Silva MR, Jobim LF, Gonçalves LF, . Occult hepatitis B in renal transplant patients. Transpl Infect Dis 2005;7:51–6.
   Google Scholar
• Stratta P, Bruschetta E, Minisini R, Barbè MC, Cornella C, Tognarelli G, . Prevalence and clinical relevance of occult hepatitis B virus infection in patients on the waiting list for kidney transplantation. Transplant Proc 2009;41:1132–7.
   Google Scholar
• Minuk GY, Sun DF, Greenberg R, Zhang M, Hawkins K, Uhanova J, . Occult hepatitis B virus infection in a North American adult hemodialysis patient population. Hepatology 2004;40:1072–7.
   PubMed Web of Science ®Google Scholar
• Hui CK, Cheung WW, Zhang HY, Au WY, Yueng YH, Leung AY, . Kinetics and risk of de novo hepatitis B infection in HBsAg-negative patients undergoing cytotoxic chemotherapy. Gastroenterology 2006;131:59–68.
   PubMed Web of Science ®Google Scholar
• Lalazar G, Rund D, Shouval D. Screening, prevention and treatment of viral hepatitis B reactivation in patients with haematological malignancies. Br J Haematol 2007;136:699–712.
   PubMed Web of Science ®Google Scholar
• Lim Y. Current status of liver diseases in Korea: hepatitis C. Korean J Hepatol 2009;15(6 Suppl):25–8.
   Google Scholar
• Kang SY, Kim MH, Lee WI. The prevalence of ‘anti-HBc alone’ and HBV DNA detection among anti-HBc alone in Korea. J Med Virol 2010;82:1508–14.
   Google Scholar
• Pereira LM, Martelli CM, Merchán-Hamann E, Montarroyos UR, Braga MC, de Lima ML, . Population-based multicentric survey of hepatitis B infection and risk factor differences among three regions in Brazil. Am J Trop Med Hyg 2009;81:240–7.
   PubMed Web of Science ®Google Scholar
• Bonanni P, Pesavento G, Bechini A, Tiscione E, Mannelli F, Benucci C, . Impact of universal vaccination programmes on the epidemiology of hepatitis B: 10 years of experience in Italy. Vaccine 2003;21:685–91.
   PubMedGoogle Scholar